Celiac Disease clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

    Sorry, in progress, not accepting new patients

    The main aim is to see how TAK-062 works to reduce celiac-related symptoms and improve small intestinal damage due to gluten exposure, in participants with celiac disease (CeD) attempting to maintain a gluten-free diet (GFD) in treated participants versus placebo controls.

    Los Angeles, California and other locations

Last updated: